Brainard Diana M, Tager Andrew M, Misdraji Joseph, Frahm Nicole, Lichterfeld Mathias, Draenert Rika, Brander Christian, Walker Bruce D, Luster Andrew D
Massachusetts General Hospital, Building 149, 13th Street, Charlestown, MA 02129, USA.
J Virol. 2007 Aug;81(16):8439-50. doi: 10.1128/JVI.00199-07. Epub 2007 Jun 6.
To exert their cytotoxic function, cytotoxic T-lymphocytes (CTL) must be recruited into infected lymphoid tissue where the majority of human immunodeficiency virus (HIV) replication occurs. Normally, effector T cells exit lymph nodes (LNs) and home to peripheral sites of infection. How HIV-specific CTL migrate into lymphoid tissue from which they are normally excluded is unknown. We investigated which chemokines and receptors mediate this reverse homing and whether impairment of this homing could contribute to CTL dysfunction as HIV infection progresses. Analysis of CTL chemokine receptor expression in the blood and LNs of untreated HIV-infected individuals with stable, chronic infection or advanced disease demonstrated that LNs were enriched for CXCR3(+) CD8 T cells in all subjects, suggesting a key role for this receptor in CTL homing to infected lymphoid tissue. Compared to subjects with chronic infection, however, subjects with advanced disease had fewer CXCR3(+) CD8 T cells in blood and LNs. CXCR3 expression on bulk and HIV-specific CD8 T cells correlated positively with CD4 count and negatively with viral load. In advanced infection, there was an accumulation of HIV-specific CD8 T cells at the effector memory stage; however, decreased numbers of CXCR3(+) CD8 T cells were seen across all maturation subsets. Plasma CXCL9 and CXCL10 were elevated in both infected groups in comparison to the levels in uninfected controls, whereas lower mRNA levels of CXCR3 ligands and CD8 in LNs were seen in advanced infection. These data suggest that both CXCR3(+) CD8 T cells and LN CXCR3 ligands decrease as HIV infection progresses, resulting in reduced homing of CTL into LNs and contributing to immune dysfunction.
为发挥其细胞毒性功能,细胞毒性T淋巴细胞(CTL)必须被招募到发生大多数人类免疫缺陷病毒(HIV)复制的感染性淋巴组织中。正常情况下,效应T细胞离开淋巴结(LN)并归巢至外周感染部位。HIV特异性CTL如何从通常将它们排除在外的淋巴组织迁移进来尚不清楚。我们研究了哪些趋化因子和受体介导这种反向归巢,以及随着HIV感染的进展,这种归巢的受损是否会导致CTL功能障碍。对未经治疗的处于稳定慢性感染或晚期疾病阶段的HIV感染者的血液和LN中CTL趋化因子受体表达的分析表明,在所有受试者中,LN富含CXCR3(+) CD8 T细胞,这表明该受体在CTL归巢至感染性淋巴组织中起关键作用。然而,与慢性感染的受试者相比,晚期疾病的受试者血液和LN中的CXCR3(+) CD8 T细胞较少。总体和HIV特异性CD8 T细胞上的CXCR3表达与CD4计数呈正相关,与病毒载量呈负相关。在晚期感染中,效应记忆阶段存在HIV特异性CD8 T细胞的积累;然而,在所有成熟亚群中均可见CXCR3(+) CD8 T细胞数量减少。与未感染对照组相比,两个感染组的血浆CXCL9和CXCL10均升高,而在晚期感染中,LN中CXCR3配体和CD8的mRNA水平较低。这些数据表明,随着HIV感染的进展,CXCR3(+) CD8 T细胞和LN CXCR3配体均减少,导致CTL归巢至LN减少,并导致免疫功能障碍。